Arch Venture Fund Vii Lp

Affiliations

  • Large Shareholder at Neumora Therapeutics Inc. (NMRA), 2023-12-13
  • Large Shareholder at 908 Devices Inc. (MASS), 2020-12-23
  • Large Shareholder at Syros Pharmaceuticals Inc. (SYRS), 2019-07-17
  • Large Shareholder at Twist Bioscience Corp (TWST), 2018-11-06
  • Large Shareholder at Unity Biotechnology Inc. (UBX), 2018-05-07
  • Other at Pulmatrix Inc. (PULM), 2018-04-12
  • Large Shareholder at Phaserx Inc. (PZRX), 2016-05-25
  • Large Shareholder at Juno Therapeutics Inc. (JUNO), 2016-03-18
  • Large Shareholder at Juno Lighting Inc (JUNO), 2016-03-18
  • Large Shareholder at Sage Therapeutics Inc. (SAGE), 2015-06-22
  • Large Shareholder at Agios Pharmaceuticals Inc (AGIO), 2015-02-23
  • Large Shareholder at Receptos Inc. (RCPT), 2014-05-15
  • Large Shareholder at Bluebird Bio Inc. (BLUE), 2013-06-26
Insider Trading: Purchases See All
Symbol Price Amount Total Value Remaining Holdings Date Form 4
MASS $20.00 300,000 $6,000,000.00 5,725,045 2020-12-22 Filing
SYRS $12.50 400,000 $5,000,000.00 4,637,137 2016-07-06 Filing
RCPT $14.00 284,485 $3,982,790.00 2,101,376 2013-05-14 Filing
Insider Trading: Sales See All
Symbol Price Amount Total Value Remaining Holdings Date Form 4
SYRS $7.70 34,521 $265,687.42 4,242,051 2019-07-17 Filing
SYRS $7.81 25,779 $201,277.28 4,276,572 2019-07-16 Filing
SYRS $8.27 2,700 $22,315.77 4,302,051 2019-07-15 Filing
SYRS $8.15 43,000 $350,441.40 4,305,051 2019-03-14 Filing
SYRS $8.20 2,820 $23,122.03 4,348,051 2019-03-13 Filing